Valbiotis SAS Financials
| ALVAL Stock | EUR 1.39 0.02 1.46% |
Valbiotis |
Understanding current and past Valbiotis SAS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Valbiotis SAS's financial statements are interrelated, with each one affecting the others. For example, an increase in Valbiotis SAS's assets may result in an increase in income on the income statement.
Valbiotis SAS Stock Summary
Valbiotis SAS competes with Kalray SA, Biosynex, Eurobio Scientific, and OSE Pharma. Valbiotis SA develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. Valbiotis SA was founded in 2014 and is based in Prigny, France. VALBIOTIS is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0013254851 |
| Business Address | rue Paul Vatine, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.valbiotis.com |
| Phone | 33 5 46 28 62 58 |
| Currency | EUR - Euro |
You should never invest in Valbiotis SAS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Valbiotis Stock, because this is throwing your money away. Analyzing the key information contained in Valbiotis SAS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Valbiotis SAS Key Financial Ratios
Valbiotis SAS's financial ratios allow both analysts and investors to convert raw data from Valbiotis SAS's financial statements into concise, actionable information that can be used to evaluate the performance of Valbiotis SAS over time and compare it to other companies across industries.| Return On Equity | -0.72 | |||
| Return On Asset | -0.22 | |||
| Target Price | 11.0 | |||
| Beta | 0.49 | |||
| Z Score | 4.8 |
Valbiotis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valbiotis SAS's current stock value. Our valuation model uses many indicators to compare Valbiotis SAS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valbiotis SAS competition to find correlations between indicators driving Valbiotis SAS's intrinsic value. More Info.Valbiotis SAS is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valbiotis SAS's earnings, one of the primary drivers of an investment's value.Valbiotis SAS Systematic Risk
Valbiotis SAS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Valbiotis SAS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Valbiotis SAS correlated with the market. If Beta is less than 0 Valbiotis SAS generally moves in the opposite direction as compared to the market. If Valbiotis SAS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Valbiotis SAS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Valbiotis SAS is generally in the same direction as the market. If Beta > 1 Valbiotis SAS moves generally in the same direction as, but more than the movement of the benchmark.
Valbiotis SAS December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Valbiotis SAS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Valbiotis SAS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Valbiotis SAS based on widely used predictive technical indicators. In general, we focus on analyzing Valbiotis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Valbiotis SAS's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.39 | |||
| Information Ratio | 0.0268 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (3.73) | |||
| Potential Upside | 7.75 |
Additional Tools for Valbiotis Stock Analysis
When running Valbiotis SAS's price analysis, check to measure Valbiotis SAS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valbiotis SAS is operating at the current time. Most of Valbiotis SAS's value examination focuses on studying past and present price action to predict the probability of Valbiotis SAS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valbiotis SAS's price. Additionally, you may evaluate how the addition of Valbiotis SAS to your portfolios can decrease your overall portfolio volatility.